Ceftobiprole: Farewell or just a delay?

Am J Health Syst Pharm. 2010 Jun 15;67(12):981. doi: 10.2146/ajhp100123.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Infections / drug therapy
  • Bacterial Infections / microbiology
  • Cephalosporins / therapeutic use*
  • Drug Approval
  • Humans
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Pseudomonas aeruginosa / drug effects
  • United States
  • United States Food and Drug Administration
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • ceftobiprole
  • Vancomycin